The application makes the power of AI accessible to pharma manufacturing while preserving GxP compliance, enabling data-driven decisions faster in the pursuit of bioreactor process optimization.

Biopharma companies must weigh the operational complexity of continuous bioprocess against its potential productivity gains.

Schematic of a typical bioreactor. Key components include the reactor tank, agitation system, feeding pump, thermal jacket, submerged aerator, and sensor probes for monitoring and maintaining optimal ...

RNA-based therapeutics are transforming medicine, but scaling production efficiently remains a challenge, particularly the cost-intensive in vitro transcription (IVT) step. Join this webinar to ...

Like an Olympian combining many precise steps on the journey to a gold medal, a bioprocessor develops a plan that turns substances from living cells into a therapy that raises its own accolades—saving ...

According to MarketsandMarkets™, the Single use Bioreactors Market is projected to reach USD 9.58 billion by 2031 from USD ...